DoseOptics LLC is a Dartmouth spinoff based in Lebanon, New Hampshire that builds BeamSite, the first FDA-cleared camera system to record radiation therapy as it happens by imaging Cherenkov light - the faint glow emitted when a radiotherapy beam passes through tissue. The technology lets radiation oncology teams literally see the beam on the patient in real time, turning an invisible treatment into a video they can review, catching positioning errors and delivery anomalies that were previously undetectable.
William Ware is the co-founder and CEO of DoseOptics LLC, a Dartmouth-affiliated medtech company in Lebanon, New Hampshire that turns a faint blue glow into a safety tool for cancer patients. Its systems image Cherenkov light - the same eerie glow seen in nuclear reactors - to show radiation dose landing on a patient in real time during treatment. A Thayer School of Engineering alumnus with a chemical engineering background, Ware has launched more than 20 patented products across pharmaceuticals, oil and gas, textiles, and medical devices, and partnered DoseOptics with Vision RT to fold Cherenkov imaging into mainstream radiotherapy.